<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Methyl-MMDA-2</id>
	<title>Methyl-MMDA-2 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Methyl-MMDA-2"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Methyl-MMDA-2&amp;action=history"/>
	<updated>2026-04-25T20:18:45Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Methyl-MMDA-2&amp;diff=6335334&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Methyl-MMDA-2&amp;diff=6335334&amp;oldid=prev"/>
		<updated>2025-02-20T01:37:30Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 01:37, 20 February 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l28&quot;&gt;Line 28:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 28:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{pharmacology-stub}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{pharmacology-stub}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;gallery&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;File:MMDMA-2.svg|Methyl-MMDA-2&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/gallery&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
	<entry>
		<id>https://wikimd.org/index.php?title=Methyl-MMDA-2&amp;diff=5375246&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Methyl-MMDA-2&amp;diff=5375246&amp;oldid=prev"/>
		<updated>2024-03-08T18:59:11Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Methyl-MMDA-2&amp;#039;&amp;#039;&amp;#039; is a [[psychedelic]] and [[entactogen]] drug of the [[phenethylamine]] class. It is a member of the [[Methylenedioxyamphetamine]] family and is closely related to [[MMDA]].&lt;br /&gt;
&lt;br /&gt;
==Chemistry==&lt;br /&gt;
Methyl-MMDA-2 is a [[substituted amphetamine]], specifically a derivative of [[3,4-methylenedioxyamphetamine]] (MDA). It has a methyl group added to the amine, hence the &amp;#039;methyl&amp;#039; in its name. The &amp;#039;2&amp;#039; in its name refers to the position of the methoxy groups on the phenyl ring, which are at the 2,5-positions.&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
The pharmacology of Methyl-MMDA-2 is not well studied. However, it is known to act as a [[serotonin]] [[receptor agonist]], and it is likely to have similar effects to other drugs in the MDA family, which are known to produce [[psychedelic effects]] and [[empathogenic effects]]. These effects are thought to be mediated by the drug&amp;#039;s action on the [[serotonin 5-HT2A receptor]].&lt;br /&gt;
&lt;br /&gt;
==Effects==&lt;br /&gt;
The effects of Methyl-MMDA-2 are not well documented, but are likely to be similar to those of other drugs in the MDA family. These can include feelings of [[euphoria]], [[visual hallucinations]], and increased [[empathy]] and [[sociability]]. However, these effects can vary greatly between individuals, and can also be influenced by factors such as dose, set and setting.&lt;br /&gt;
&lt;br /&gt;
==Risks==&lt;br /&gt;
As with all [[psychoactive drugs]], Methyl-MMDA-2 carries risks. These can include [[psychological dependence]], [[neurotoxicity]], and [[serotonin syndrome]] if taken in combination with certain other drugs. It is also possible that it could have similar risks to other drugs in the MDA family, such as [[cardiovascular]] risks.&lt;br /&gt;
&lt;br /&gt;
==Legal Status==&lt;br /&gt;
The legal status of Methyl-MMDA-2 varies by country. In some countries, it may be controlled under analogue laws, which cover substances that are similar in structure to controlled drugs.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[MMDA]]&lt;br /&gt;
* [[MDMA]]&lt;br /&gt;
* [[Psychedelic drug]]&lt;br /&gt;
* [[Entactogen]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Psychedelic drugs]]&lt;br /&gt;
[[Category:Entactogens]]&lt;br /&gt;
[[Category:Substituted amphetamines]]&lt;br /&gt;
[[Category:Serotonin receptor agonists]]&lt;br /&gt;
&lt;br /&gt;
{{pharmacology-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>